Article
Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Biochemical and biophysical research communications - 28 Aug 1998
Phylactou L A, Tsipouras P, Kilpatrick M W
Abstract excerpt
Hammerhead ribozymes are catalytic RNA molecules that can act in trans, with ribozyme and substrate being two different oligoribonucleotides with regions of complementarity. Mutations in the gene for fibrillin-1 (FBN1) cause Marfan syndrome. The majority of mutations are single-base changes, many of which exert their effect via a dominant-negative mechanism. Previously we have shown that an antisense hammerhead...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
